http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022033471-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecc6b952a46b5526ae6cb515e2030b15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc8b706fb22ca0baba35f66ce3e501ef
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2021-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa8056e0eb57773c61b3c68d2e1c12f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f3b1cc9153585d8df8f60a64da377a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56ecc420f8cc5b9d818b79ec2b4928d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b5ea6e6ff4957f37d8f9b7866322b1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f66ded4b89a2b7d4b32abe2580035871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2850ada515e083db55ccc04ce608d132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea1f0059a2c5e7c6c4823eaf2ef8c8f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8fe1dc541efcc25a4b0113307dbfbe3
publicationDate 2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022033471-A1
titleOfInvention Salt of ortho-aminopyridynyl-containing compound, preparation method therefor and use thereof
abstract Provided in the present invention are a salt of an ortho-aminopyridynyl-containing compound as shown in formula (2), a solvate or hydrate thereof, a preparation method therefor and use thereof. The salt obtained in the present invention has good crystallinity, and compared with a free form of the compound, the solubility in water is obviously improved. The preferred salt form and crystal form have low hygroscopicity, and can be stably present. Therefore, compared with the free form of the compound or other salts, the salt is more beneficial for use as a drug.
priorityDate 2020-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146386698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425797829

Total number of triples: 28.